| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Aneurysm | 5 | 2021 | 237 | 1.300 |
Why?
|
| Aortic Aneurysm, Thoracic | 11 | 2021 | 705 | 1.180 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2020 | 500 | 1.110 |
Why?
|
| Endothelium, Vascular | 9 | 2011 | 487 | 1.110 |
Why?
|
| Palmitic Acid | 5 | 2017 | 29 | 1.070 |
Why?
|
| Endothelial Cells | 7 | 2020 | 527 | 0.960 |
Why?
|
| Thioredoxins | 3 | 2010 | 26 | 0.930 |
Why?
|
| Aorta | 10 | 2019 | 552 | 0.860 |
Why?
|
| Nitric Oxide Synthase Type III | 8 | 2008 | 192 | 0.820 |
Why?
|
| Apoptosis | 7 | 2021 | 1892 | 0.790 |
Why?
|
| Reactive Oxygen Species | 3 | 2010 | 518 | 0.750 |
Why?
|
| Up-Regulation | 9 | 2011 | 876 | 0.680 |
Why?
|
| Interferon Regulatory Factor-3 | 2 | 2017 | 21 | 0.680 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 5 | 2010 | 126 | 0.670 |
Why?
|
| Forkhead Transcription Factors | 4 | 2012 | 381 | 0.660 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2006 | 254 | 0.650 |
Why?
|
| Cells, Cultured | 18 | 2017 | 3036 | 0.610 |
Why?
|
| Muscle, Smooth, Vascular | 7 | 2017 | 238 | 0.580 |
Why?
|
| ADAMTS4 Protein | 2 | 2017 | 12 | 0.580 |
Why?
|
| Venous Thrombosis | 1 | 2020 | 172 | 0.580 |
Why?
|
| Myocytes, Smooth Muscle | 7 | 2021 | 189 | 0.570 |
Why?
|
| Versicans | 1 | 2017 | 17 | 0.550 |
Why?
|
| Nucleotidyltransferases | 1 | 2017 | 49 | 0.530 |
Why?
|
| RNA, Small Interfering | 7 | 2010 | 687 | 0.510 |
Why?
|
| Thrombomodulin | 2 | 2020 | 19 | 0.490 |
Why?
|
| Homeostasis | 1 | 2020 | 722 | 0.490 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 257 | 0.480 |
Why?
|
| Thrombosis | 1 | 2020 | 524 | 0.460 |
Why?
|
| Phosphoproteins | 1 | 2017 | 442 | 0.450 |
Why?
|
| Activating Transcription Factor 2 | 3 | 2010 | 16 | 0.450 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2017 | 624 | 0.430 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2013 | 87 | 0.400 |
Why?
|
| Pulmonary Medicine | 1 | 2013 | 29 | 0.390 |
Why?
|
| Membrane Proteins | 2 | 2017 | 1610 | 0.390 |
Why?
|
| Angiotensin II | 5 | 2021 | 163 | 0.390 |
Why?
|
| Mitochondria | 1 | 2017 | 747 | 0.370 |
Why?
|
| Histone Deacetylases | 2 | 2010 | 122 | 0.360 |
Why?
|
| Gene Expression Regulation | 4 | 2010 | 2438 | 0.350 |
Why?
|
| Insulin | 2 | 2006 | 1168 | 0.350 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 249 | 0.320 |
Why?
|
| MAP Kinase Signaling System | 3 | 2006 | 309 | 0.320 |
Why?
|
| Signal Transduction | 8 | 2020 | 4703 | 0.310 |
Why?
|
| Lung Diseases | 1 | 2013 | 408 | 0.300 |
Why?
|
| Mice, Knockout | 6 | 2020 | 3863 | 0.300 |
Why?
|
| Metformin | 1 | 2010 | 166 | 0.280 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2009 | 175 | 0.280 |
Why?
|
| Cytomegalovirus | 2 | 2006 | 259 | 0.270 |
Why?
|
| Aorta, Thoracic | 7 | 2017 | 540 | 0.270 |
Why?
|
| Venous Thromboembolism | 1 | 2010 | 186 | 0.260 |
Why?
|
| Fatty Acids | 1 | 2009 | 356 | 0.260 |
Why?
|
| Gene Expression Regulation, Enzymologic | 5 | 2008 | 246 | 0.260 |
Why?
|
| Cell Differentiation | 3 | 2019 | 1960 | 0.260 |
Why?
|
| Forkhead Box Protein O1 | 3 | 2012 | 97 | 0.250 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2006 | 116 | 0.250 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 482 | 0.240 |
Why?
|
| Resistin | 1 | 2006 | 30 | 0.240 |
Why?
|
| Glucose | 2 | 2017 | 878 | 0.240 |
Why?
|
| Repressor Proteins | 1 | 2010 | 812 | 0.230 |
Why?
|
| Promoter Regions, Genetic | 6 | 2012 | 1280 | 0.220 |
Why?
|
| Humans | 36 | 2021 | 132132 | 0.210 |
Why?
|
| Carrier Proteins | 1 | 2009 | 1047 | 0.210 |
Why?
|
| Cytomegalovirus Infections | 1 | 2005 | 223 | 0.200 |
Why?
|
| Procollagen-Proline Dioxygenase | 3 | 2008 | 35 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 4757 | 0.200 |
Why?
|
| Disease Models, Animal | 5 | 2021 | 4688 | 0.200 |
Why?
|
| Mice | 8 | 2021 | 18507 | 0.180 |
Why?
|
| Blotting, Western | 4 | 2010 | 1077 | 0.180 |
Why?
|
| Caspase 1 | 2 | 2021 | 49 | 0.180 |
Why?
|
| China | 2 | 2013 | 290 | 0.170 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2010 | 236 | 0.170 |
Why?
|
| Thromboplastin | 1 | 2020 | 20 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2017 | 1672 | 0.160 |
Why?
|
| Animals | 11 | 2021 | 34882 | 0.160 |
Why?
|
| RNA, Messenger | 8 | 2013 | 2674 | 0.160 |
Why?
|
| Proteolysis | 2 | 2017 | 198 | 0.160 |
Why?
|
| Blood Coagulation | 1 | 2020 | 130 | 0.160 |
Why?
|
| Case-Control Studies | 5 | 2013 | 3418 | 0.150 |
Why?
|
| Inflammasomes | 2 | 2021 | 167 | 0.150 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2012 | 137 | 0.150 |
Why?
|
| Diet, High-Fat | 2 | 2017 | 254 | 0.150 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2012 | 424 | 0.150 |
Why?
|
| Atherosclerosis | 3 | 2013 | 1010 | 0.140 |
Why?
|
| Phosphorylation | 3 | 2012 | 1608 | 0.130 |
Why?
|
| Hepatitis | 1 | 2017 | 58 | 0.130 |
Why?
|
| Protein Binding | 2 | 2012 | 1729 | 0.130 |
Why?
|
| Aged | 10 | 2017 | 21442 | 0.130 |
Why?
|
| DNA-Binding Proteins | 4 | 2021 | 1977 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 1284 | 0.130 |
Why?
|
| Elastic Tissue | 2 | 2013 | 20 | 0.130 |
Why?
|
| Enzyme Activation | 3 | 2006 | 615 | 0.130 |
Why?
|
| Vasoconstriction | 1 | 2017 | 104 | 0.130 |
Why?
|
| Middle Aged | 11 | 2017 | 29003 | 0.120 |
Why?
|
| Fibroblasts | 3 | 2019 | 861 | 0.120 |
Why?
|
| Hepatocytes | 1 | 2017 | 237 | 0.120 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 139 | 0.120 |
Why?
|
| Structure-Activity Relationship | 1 | 2017 | 588 | 0.120 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2017 | 131 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2008 | 664 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2019 | 294 | 0.110 |
Why?
|
| RNA | 2 | 2008 | 551 | 0.110 |
Why?
|
| Introns | 4 | 2008 | 305 | 0.110 |
Why?
|
| Chemistry, Clinical | 1 | 2014 | 12 | 0.110 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2014 | 39 | 0.110 |
Why?
|
| Muscle Proteins | 1 | 2017 | 407 | 0.110 |
Why?
|
| Transcription Factors | 3 | 2017 | 2493 | 0.100 |
Why?
|
| Cell Movement | 1 | 2017 | 889 | 0.100 |
Why?
|
| Aortitis | 1 | 2012 | 7 | 0.100 |
Why?
|
| Procollagen N-Endopeptidase | 1 | 2012 | 11 | 0.100 |
Why?
|
| Transcription Factor AP-1 | 1 | 2013 | 110 | 0.100 |
Why?
|
| PPAR gamma | 1 | 2013 | 88 | 0.100 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2012 | 40 | 0.100 |
Why?
|
| Enzyme Induction | 1 | 2012 | 98 | 0.100 |
Why?
|
| Thiazolidinediones | 1 | 2013 | 81 | 0.100 |
Why?
|
| Receptor, Notch1 | 1 | 2012 | 76 | 0.100 |
Why?
|
| ADAM Proteins | 1 | 2012 | 84 | 0.090 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 2147 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2017 | 2508 | 0.090 |
Why?
|
| Male | 14 | 2019 | 64985 | 0.090 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 417 | 0.090 |
Why?
|
| Apolipoproteins E | 2 | 2011 | 200 | 0.090 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 68 | 0.090 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2012 | 39 | 0.090 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2017 | 426 | 0.090 |
Why?
|
| Forecasting | 1 | 2013 | 372 | 0.090 |
Why?
|
| Cadmium | 1 | 2011 | 31 | 0.090 |
Why?
|
| Collagen Type III | 2 | 2013 | 25 | 0.090 |
Why?
|
| Vasculitis | 1 | 2011 | 50 | 0.090 |
Why?
|
| DNA Primers | 2 | 2009 | 636 | 0.090 |
Why?
|
| Collagen Type I | 2 | 2013 | 121 | 0.090 |
Why?
|
| Public Health | 1 | 2013 | 281 | 0.090 |
Why?
|
| Elastin | 2 | 2013 | 31 | 0.080 |
Why?
|
| Plasmids | 2 | 2009 | 459 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 361 | 0.080 |
Why?
|
| Reference Values | 1 | 2012 | 708 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2017 | 3351 | 0.080 |
Why?
|
| Disease Progression | 2 | 2013 | 2226 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1011 | 0.080 |
Why?
|
| PPAR alpha | 1 | 2010 | 53 | 0.080 |
Why?
|
| Fenofibrate | 1 | 2010 | 61 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 93 | 0.080 |
Why?
|
| Transfection | 3 | 2006 | 996 | 0.080 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2009 | 19 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 196 | 0.080 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2009 | 31 | 0.080 |
Why?
|
| Ribonucleotides | 1 | 2009 | 32 | 0.080 |
Why?
|
| Protein Kinases | 1 | 2010 | 331 | 0.070 |
Why?
|
| Octamer Transcription Factors | 1 | 2008 | 9 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1694 | 0.070 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2008 | 20 | 0.070 |
Why?
|
| Gene Silencing | 2 | 2006 | 238 | 0.070 |
Why?
|
| Myocardium | 1 | 2013 | 908 | 0.070 |
Why?
|
| Nucleotides | 1 | 2008 | 89 | 0.070 |
Why?
|
| Histones | 2 | 2008 | 534 | 0.070 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 1 | 2007 | 7 | 0.070 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2007 | 12 | 0.070 |
Why?
|
| Antioxidants | 1 | 2010 | 333 | 0.070 |
Why?
|
| Linoleic Acid | 1 | 2006 | 17 | 0.060 |
Why?
|
| Female | 10 | 2017 | 70725 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1548 | 0.060 |
Why?
|
| Binding Sites | 2 | 2006 | 1256 | 0.060 |
Why?
|
| Immediate-Early Proteins | 1 | 2006 | 58 | 0.060 |
Why?
|
| Oncogene Protein v-akt | 1 | 2005 | 33 | 0.060 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2005 | 18 | 0.060 |
Why?
|
| Hydroxamic Acids | 1 | 2005 | 60 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2006 | 124 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2010 | 489 | 0.060 |
Why?
|
| Hypertension | 2 | 2014 | 1396 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2006 | 1347 | 0.060 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2005 | 86 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2010 | 803 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2005 | 152 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2006 | 1422 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2008 | 604 | 0.050 |
Why?
|
| Actins | 1 | 2005 | 334 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2006 | 492 | 0.050 |
Why?
|
| Risk Factors | 1 | 2017 | 10949 | 0.050 |
Why?
|
| Macrophages | 2 | 2019 | 689 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 605 | 0.050 |
Why?
|
| Time Factors | 2 | 2014 | 6454 | 0.040 |
Why?
|
| Cell Line | 1 | 2006 | 2719 | 0.040 |
Why?
|
| Models, Biological | 1 | 2006 | 1443 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2006 | 697 | 0.040 |
Why?
|
| Gene Expression | 3 | 2012 | 1558 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2013 | 133 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 2 | 2010 | 36 | 0.040 |
Why?
|
| Inflammation | 1 | 2006 | 1517 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2012 | 677 | 0.030 |
Why?
|
| Glyburide | 1 | 2017 | 23 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2006 | 2849 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2017 | 100 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 2017 | 118 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2012 | 13034 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2017 | 259 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2008 | 731 | 0.030 |
Why?
|
| Rats | 2 | 2013 | 3611 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 2 | 2010 | 473 | 0.030 |
Why?
|
| Phenotype | 2 | 2017 | 4529 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2019 | 550 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 381 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 2008 | 587 | 0.030 |
Why?
|
| Citric Acid | 1 | 2014 | 39 | 0.030 |
Why?
|
| Glycosaminoglycans | 1 | 2013 | 34 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2013 | 37 | 0.030 |
Why?
|
| Blood Specimen Collection | 1 | 2014 | 47 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 2445 | 0.030 |
Why?
|
| CD3 Complex | 1 | 2013 | 90 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2013 | 101 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2013 | 60 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2013 | 113 | 0.020 |
Why?
|
| Myofibroblasts | 1 | 2013 | 64 | 0.020 |
Why?
|
| ADAMTS1 Protein | 1 | 2012 | 16 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 2092 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2012 | 105 | 0.020 |
Why?
|
| Heparin | 1 | 2014 | 212 | 0.020 |
Why?
|
| Base Sequence | 2 | 2008 | 2899 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2013 | 151 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2012 | 117 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2013 | 329 | 0.020 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 54 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 238 | 0.020 |
Why?
|
| Aortic Rupture | 1 | 2013 | 119 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 3770 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2013 | 431 | 0.020 |
Why?
|
| Chaperonin 60 | 1 | 2011 | 32 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 333 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2011 | 65 | 0.020 |
Why?
|
| Acute Disease | 1 | 2014 | 1160 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 865 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 2010 | 58 | 0.020 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2011 | 152 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2010 | 176 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2014 | 609 | 0.020 |
Why?
|
| Collagen | 1 | 2010 | 308 | 0.020 |
Why?
|
| Protein Deglycase DJ-1 | 1 | 2008 | 16 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2008 | 21 | 0.020 |
Why?
|
| Acetylation | 1 | 2008 | 191 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2008 | 144 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2008 | 454 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2008 | 412 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 3020 | 0.020 |
Why?
|
| Compliance | 1 | 2006 | 18 | 0.020 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2006 | 21 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 2006 | 59 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 89 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2006 | 138 | 0.020 |
Why?
|
| Luciferases | 1 | 2006 | 129 | 0.020 |
Why?
|
| Response Elements | 1 | 2006 | 98 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 109 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2008 | 363 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2006 | 177 | 0.010 |
Why?
|
| Caspases | 1 | 2006 | 165 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 573 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2006 | 303 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2005 | 365 | 0.010 |
Why?
|
| Biomarkers | 1 | 2014 | 3405 | 0.010 |
Why?
|
| Adult | 3 | 2014 | 31585 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2005 | 444 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2006 | 771 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 803 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2008 | 1122 | 0.010 |
Why?
|
| Smoking | 1 | 2006 | 940 | 0.010 |
Why?
|
| DNA | 1 | 2006 | 1473 | 0.010 |
Why?
|
| Genotype | 1 | 2006 | 2697 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 1882 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 7108 | 0.010 |
Why?
|
| Adolescent | 1 | 2006 | 20564 | 0.000 |
Why?
|